Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.

Clinical and experimental rheumatology - 1 Jan 2000

Notarstefano Chiara, Croia Cristina, Pontarini Elena, Lucchesi Davide, Sutcliffe Nurhan, Tappuni Anwar, Donati Valentina, Pitzalis Costantino, Baldini Chiara, Bombardieri Michele

Abstract excerpt

OBJECTIVES: ACA-positive/primary Sjögren's syndrome (pSS) represents a distinct overlapping entity with intermediate features in between limited systemic sclerosis (lSSc) and pSS. Few data are available on their general risk for lymphoproliferative complications, specifically regarding adverse predictors at the level of minor salivary gland (MSG) histology. The objectives of this work are: a) to characterise,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to Antigens, CD20

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD3 Complex

Share to London

Share to Lymphoproliferative Disorders

Share to Receptors, Complement 3d

Share to Salivary Gland Neoplasms

Share to Sjogren's Syndrome

Source

Identifiers

PMID: 30156540

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.PMID 30156540Read ↗

The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy.Semantic proximity Read ↗

Sjögren's syndrome: one year in review 2022Semantic proximity Read ↗

Impact of double positive for anti-centromere and anti-SS-a/Ro antibodies on clinicopathological characteristics of primary Sjögren’s syndrome: a retrospective cohort studySemantic proximity Read ↗

Primary Sjӧgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers.Semantic proximity Read ↗

Sjögren's syndrome: one year in review 2023Semantic proximity Read ↗

Current views on the pathogenesis of Sjögren's syndrome.Semantic proximity Read ↗

Differences in clinical phenotypes of primary Sjögren's syndrome depending on early or late onset.Semantic proximity Read ↗

Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.Semantic proximity Read ↗

[Lymphoproliferative disorders in Sjögren's syndrome].Semantic proximity Read ↗

Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.Semantic proximity Read ↗

B cells in the pathogenesis of primary Sjögren syndrome.Semantic proximity Read ↗

Is the T Follicular Regulatory:Follicular Helper T Cell Ratio in Blood a Biomarker for Ectopic Lymphoid Structure Formation in Sjögren's Syndrome? Comment on the Article by Fonseca et alSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.